Parse Biosciences, a QIAGEN company and the leading provider of scalable and accessible single-cell sequencing solutions, today announced the commercial availability of Evercode™ Whole Transcriptome ...
BostonGene, developer of the leading AI foundation model for tumor and immune biology, announced results from the FEASY study in collaboration with The University of Texas MD Anderson Cancer Center, ...
While RNA sequencing (RNA-seq) has become a standard tool for profiling which genes are active in an organism, determining ...
A collaboration between Karolinska Institutet, Karolinska University Hospital, and SciLifeLab has integrated whole genome sequencing into routine diagnostic investigations for rare diseases at ...
Madras Diabetes Research Foundation and Premas Life Sciences collaborate to enhance genomics research for improved diabetes ...
New research indicates that a greater number of women could benefit from targeted therapies for breast and ovarian cancer, following a landmark study that mapped mutations within tumours. Experts from ...
Sam Altman highlighted Paul Conyngham’s use of AI tools to design a cancer treatment for his dog Rosie, showing how AI can ...
Botstein, Princeton’s Anthony B. Evnin ‘62 Professor of Genomics, Emeritus, and an emeritus professor of molecular biology ...
Scalp tape-strips may represent a new, minimally invasive means by which to assess disease activity and treatment response in ...
Genomics improves healthcare and prevention of all major diseases by early personalized insight into health, and Europe needs ...
An international team led by researchers from the Yong Loo Lin School of Medicine, National University of Singapore (NUS ...
New details from investigators reveal a crucial safety system failed before a deadly plane collision at LaGuardia Airport.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results